The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Lymphoma, Large-Cell

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Lymphoma, Large-Cell


High impact information on Lymphoma, Large-Cell


Chemical compound and disease context of Lymphoma, Large-Cell


Biological context of Lymphoma, Large-Cell


Anatomical context of Lymphoma, Large-Cell


Gene context of Lymphoma, Large-Cell


Analytical, diagnostic and therapeutic context of Lymphoma, Large-Cell


  1. Letter: Reticulum-cell sarcoma and Sjögren's syndrome in a patient treated with azathioprine. Slater, A., Whittaker, J.A., Fisher, D.J. N. Engl. J. Med. (1976) [Pubmed]
  2. Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-kappa B. Mathas, S., Hinz, M., Anagnostopoulos, I., Krappmann, D., Lietz, A., Jundt, F., Bommert, K., Mechta-Grigoriou, F., Stein, H., Dörken, B., Scheidereit, C. EMBO J. (2002) [Pubmed]
  3. Deregulation of PAX-5 by translocation of the Emu enhancer of the IgH locus adjacent to two alternative PAX-5 promoters in a diffuse large-cell lymphoma. Busslinger, M., Klix, N., Pfeffer, P., Graninger, P.G., Kozmik, Z. Proc. Natl. Acad. Sci. U.S.A. (1996) [Pubmed]
  4. Expression of the novel intermediate filament-associated protein restin in Hodgkin's disease and anaplastic large-cell lymphoma. Delabie, J., Shipman, R., Brüggen, J., De Strooper, B., van Leuven, F., Tarcsay, L., Cerletti, N., Odink, K., Diehl, V., Bilbe, G. Blood (1992) [Pubmed]
  5. Formation of ion-permeable channels by tumor necrosis factor-alpha. Kagan, B.L., Baldwin, R.L., Munoz, D., Wisnieski, B.J. Science (1992) [Pubmed]
  6. Driven by the same Ig enhancer and SV40 T promoter ras induced lung adenomatous tumors, myc induced pre-B cell lymphomas and SV40 large T gene a variety of tumors in transgenic mice. Suda, Y., Aizawa, S., Hirai, S., Inoue, T., Furuta, Y., Suzuki, M., Hirohashi, S., Ikawa, Y. EMBO J. (1987) [Pubmed]
  7. Cell membrane-specific epitopes on CD30: Potentially superior targets for immunotherapy. Nagata, S., Ise, T., Onda, M., Nakamura, K., Ho, M., Raubitschek, A., Pastan, I.H. Proc. Natl. Acad. Sci. U.S.A. (2005) [Pubmed]
  8. Retinoblastoma protein directly interacts with and activates the transcription factor NF-IL6. Chen, P.L., Riley, D.J., Chen-Kiang, S., Lee, W.H. Proc. Natl. Acad. Sci. U.S.A. (1996) [Pubmed]
  9. Vascular endothelial cell growth factor (VEGF) produced by A-431 human epidermoid carcinoma cells and identification of VEGF membrane binding sites. Myoken, Y., Kayada, Y., Okamoto, T., Kan, M., Sato, G.H., Sato, J.D. Proc. Natl. Acad. Sci. U.S.A. (1991) [Pubmed]
  10. Immune response to the ALK oncogenic tyrosine kinase in patients with anaplastic large-cell lymphoma. Pulford, K., Falini, B., Banham, A.H., Codrington, D., Roberton, H., Hatton, C., Mason, D.Y. Blood (2000) [Pubmed]
  11. Reduction in drug-induced DNA double-strand breaks associated with beta1 integrin-mediated adhesion correlates with drug resistance in U937 cells. Hazlehurst, L.A., Valkov, N., Wisner, L., Storey, J.A., Boulware, D., Sullivan, D.M., Dalton, W.S. Blood (2001) [Pubmed]
  12. Retinoids downregulate both p60 and p80 forms of tumor necrosis factor receptors in human histiocytic lymphoma U-937 cells. Totpal, K., Chaturvedi, M.M., LaPushin, R., Aggarwal, B.B. Blood (1995) [Pubmed]
  13. Elimination of clonogenic tumor cells from HL-60, Daudi, and U-937 cell lines by laser photoradiation therapy: implications for autologous bone marrow purging. Gulliya, K.S., Pervaiz, S. Blood (1989) [Pubmed]
  14. Plasminogen activator inhibitor 2: regulation of gene transcription during phorbol ester-mediated differentiation of U-937 human histiocytic lymphoma cells. Schleuning, W.D., Medcalf, R.L., Hession, C., Rothenbühler, R., Shaw, A., Kruithof, E.K. Mol. Cell. Biol. (1987) [Pubmed]
  15. c-FLIP confers resistance to FAS-mediated apoptosis in anaplastic large-cell lymphoma. Oyarzo, M.P., Medeiros, L.J., Atwell, C., Feretzaki, M., Leventaki, V., Drakos, E., Amin, H.M., Rassidakis, G.Z. Blood (2006) [Pubmed]
  16. TRK-fused gene (TFG) is a new partner of ALK in anaplastic large cell lymphoma producing two structurally different TFG-ALK translocations. Hernández, L., Pinyol, M., Hernández, S., Beà, S., Pulford, K., Rosenwald, A., Lamant, L., Falini, B., Ott, G., Mason, D.Y., Delsol, G., Campo, E. Blood (1999) [Pubmed]
  17. Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma. Jundt, F., Anagnostopoulos, I., Förster, R., Mathas, S., Stein, H., Dörken, B. Blood (2002) [Pubmed]
  18. Clonal relation in a case of CLL, ALCL, and Hodgkin composite lymphoma. van den Berg, A., Maggio, E., Rust, R., Kooistra, K., Diepstra, A., Poppema, S. Blood (2002) [Pubmed]
  19. Nodular lymphocyte-predominant Hodgkin's disease associated with large-cell lymphoma: analysis of Ig gene rearrangements by V-J polymerase chain reaction. Greiner, T.C., Gascoyne, R.D., Anderson, M.E., Kingma, D.W., Adomat, S.A., Said, J., Jaffe, E.S. Blood (1996) [Pubmed]
  20. A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor. Kohno, T., Brewer, M.T., Baker, S.L., Schwartz, P.E., King, M.W., Hale, K.K., Squires, C.H., Thompson, R.C., Vannice, J.L. Proc. Natl. Acad. Sci. U.S.A. (1990) [Pubmed]
  21. Frequent expression of the B-cell-specific activator protein in Reed-Sternberg cells of classical Hodgkin's disease provides further evidence for its B-cell origin. Foss, H.D., Reusch, R., Demel, G., Lenz, G., Anagnostopoulos, I., Hummel, M., Stein, H. Blood (1999) [Pubmed]
  22. B-cell lineage confers a favorable outcome among children and adolescents with large-cell lymphoma: a Pediatric Oncology Group study. Hutchison, R.E., Berard, C.W., Shuster, J.J., Link, M.P., Pick, T.E., Murphy, S.B. J. Clin. Oncol. (1995) [Pubmed]
  23. 2-Deoxy-D-glucose enhances sensitivity of human histiocytic lymphoma U937 cells to apoptosis induced by tumor necrosis factor. Halicka, H.D., Ardelt, B., Li, X., Melamed, M.M., Darzynkiewicz, Z. Cancer Res. (1995) [Pubmed]
  24. Human interleukin-10 expression in T/natural killer-cell lymphomas: association with anaplastic large cell lymphomas and nasal natural killer-cell lymphomas. Boulland, M.L., Meignin, V., Leroy-Viard, K., Copie-Bergman, C., Brière, J., Touitou, R., Kanavaros, P., Gaulard, P. Am. J. Pathol. (1998) [Pubmed]
  25. Nucleophosmin-anaplastic lymphoma kinase of anaplastic large-cell lymphoma recruits, activates, and uses pp60c-src to mediate its mitogenicity. Cussac, D., Greenland, C., Roche, S., Bai, R.Y., Duyster, J., Morris, S.W., Delsol, G., Allouche, M., Payrastre, B. Blood (2004) [Pubmed]
  26. Expression pattern of T-cell-associated chemokine receptors and their chemokines correlates with specific subtypes of T-cell non-Hodgkin lymphoma. Jones, D., O'Hara, C., Kraus, M.D., Perez-Atayde, A.R., Shahsafaei, A., Wu, L., Dorfman, D.M. Blood (2000) [Pubmed]
  27. Expression levels of apoptosis-related proteins predict clinical outcome in anaplastic large cell lymphoma. ten Berge, R.L., Meijer, C.J., Dukers, D.F., Kummer, J.A., Bladergroen, B.A., Vos, W., Hack, C.E., Ossenkoppele, G.J., Oudejans, J.J. Blood (2002) [Pubmed]
  28. Inv(2)(p23q35) in anaplastic large-cell lymphoma induces constitutive anaplastic lymphoma kinase (ALK) tyrosine kinase activation by fusion to ATIC, an enzyme involved in purine nucleotide biosynthesis. Ma, Z., Cools, J., Marynen, P., Cui, X., Siebert, R., Gesk, S., Schlegelberger, B., Peeters, B., De Wolf-Peeters, C., Wlodarska, I., Morris, S.W. Blood (2000) [Pubmed]
  29. A new fusion gene TPM3-ALK in anaplastic large cell lymphoma created by a (1;2)(q25;p23) translocation. Lamant, L., Dastugue, N., Pulford, K., Delsol, G., Mariamé, B. Blood (1999) [Pubmed]
  30. Primary systemic CD30 (Ki-1)-positive anaplastic large cell lymphoma of the adult: sequential intensive treatment with the F-MACHOP regimen (+/- radiotherapy) and autologous bone marrow transplantation. Fanin, R., Silvestri, F., Geromin, A., Cerno, M., Infanti, L., Zaja, F., Barillari, G., Savignano, C., Rinaldi, C., Damiani, D., Buffoli, A., Biffoni, F., Baccarini, M. Blood (1996) [Pubmed]
  31. AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy. Lim, S.T., Karim, R., Nathwani, B.N., Tulpule, A., Espina, B., Levine, A.M. J. Clin. Oncol. (2005) [Pubmed]
  32. Apoptosis induced by cadmium in human lymphoma U937 cells through Ca2+-calpain and caspase-mitochondria- dependent pathways. Li, M., Kondo, T., Zhao, Q.L., Li, F.J., Tanabe, K., Arai, Y., Zhou, Z.C., Kasuya, M. J. Biol. Chem. (2000) [Pubmed]
  33. Signal transducer and activator of transcription-3 activation contributes to high tissue inhibitor of metalloproteinase-1 expression in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma. Lai, R., Rassidakis, G.Z., Medeiros, L.J., Ramdas, L., Goy, A.H., Cutler, C., Fujio, Y., Kunisada, K., Amin, H.M., Gilles, F. Am. J. Pathol. (2004) [Pubmed]
  34. Xanthine nephropathy during chemotherapy in deficiency of hypoxanthine-guanine phosphoribosyltransferase. Gomez, G.A., Stutzman, L., Chu, T.M. Arch. Intern. Med. (1978) [Pubmed]
WikiGenes - Universities